Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Hematology/Oncology and Stem Cell Therapy|October 11, 2014
Rare but authentic Philadelphia-positive acute myeloblastic leukemia: two case reports and a literature review of characteristics, treatment and outcomeEmilie Reboursiere, Sylvain Chantepie, Anne-Claire Gac, et al.
Case Reports in Medicine|November 19, 2009
Full response of a localized renal tumour after reduced-intensity conditioned hematopoietic stem cell transplantationAnne-Claire Gac, Sylvain Chantepie, Michel Leporrier, et al.
Journal of Fungi (Basel, Switzerland)|December 27, 2024
Epidemiology, Clinical, Radiological and Biological Characteristics, and Outcomes of Mucormycosis: A Retrospective Study at a French University HospitalTom Cartau, Sylvain Chantepie, Angélique Thuillier-Lecouf, et al.
European Journal of Haematology|December 19, 2025
Prevalence and Diagnostic Challenge of Hemophagocytic Lymphohistiocytosis Syndrome in Critically Ill PatientsClaire Queffeulou, Mathieu Bellal, Suzanne Goursaud, et al.
Joint Bone Spine|April 7, 2024
VEXAS syndrome: A new mimicker of idiopathic multicentric Castleman diseaseRémi Philip, Vincent Cadro, Achille Aouba, et al.
Leukemia Research|August 12, 2011
Dynamics of procalcitonin and bacteremia in neutropenic adults with acute myeloid leukemiaAnne-Claire Gac, Jean-Jacques Parienti, Sylvain Chantepie, et al.
Psychological Medicine|February 11, 2020
Haematologic malignancies associated with clozapine v. all other antipsychotic agents: a pharmacovigilance study in VigiBase®Basile Chrétien, Véronique Lelong-Boulouard, Sylvain Chantepie, et al.
Clinical Rheumatology|March 9, 2018
Eculizumab reversed severe distal ischemic syndrome and glomerulonephritis with isolated C3 deposits associated with anti-factor H autoantibodies: a case reportSamuel Deshayes, Nicolas Martin Silva, Valérie Chatelet, et al.
Bulletin Du Cancer|January 9, 2019
[Prophylaxis of infections post-allogeneic transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Philippe Lewalle, Cécile Pochon, Mauricette Michallet, et al.
American Journal of Hematology|November 11, 2011
Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: a phase 1/2 study of the acute leukemia French associationHassan Farhat, Oumedaly Reman, Emmanuel Raffoux, et al.
Pageof 7